Securities Class Action

In Litigation

0

Settlement

0

Closed

1

Total Settlement

$0

Material Events

Critical Governance & Disclosure

4

Board, Voting & Shareholder Rights

5

Capital Structure & Financial Risk

1

Disclosure & Communications

18

SEC Filings

Form 4

Statement of changes in beneficial ownership of securities

2026-11-10

View Form 4 Statement of changes in beneficial ownership of securities on SEC.gov
8-K

Current report

2026-11-09

View 8-K Current report on SEC.gov
8-K

Current report

2026-11-09

View 8-K Current report on SEC.gov
DEFA14A

Additional definitive proxy soliciting materials and Rule 14(a)(12) material

2026-11-09

View DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material on SEC.gov
DEFA14A

Additional definitive proxy soliciting materials and Rule 14(a)(12) material

2026-11-09

View DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material on SEC.gov

Insider Transaction

No Insider Transactions found for HERON THERAPEUTICS, INC. /DE/